Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, male-predominant hematologic malignancy with poor outcomes and with just one recently approved agent (tagraxofusp). It is characterized by the abnormal proliferation of precursor plasmacytoid dendritic cells (pDCs) with morphologic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Beird, Hannah C., Khan, Maliha, Wang, Feng, Alfayez, Mansour, Cai, Tianyu, Zhao, Li, Khoury, Joseph, Futreal, P. Andrew, Konopleva, Marina, Pemmaraju, Naveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898719/
https://www.ncbi.nlm.nih.gov/pubmed/31811114
http://dx.doi.org/10.1038/s41408-019-0262-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898719/
https://www.ncbi.nlm.nih.gov/pubmed/31811114
http://dx.doi.org/10.1038/s41408-019-0262-0

Ejemplares similares